Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of oxytocin for adequate uterine tone during cesarean section in high- and low-risk patients
IRCT20120430009593N11Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, single-blind trial of oxytocin in uterine atony (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: ED90 of oxytocin in low-risk patients, ED90 of oxytocin in high-risk patients and 1 more. Started Nov 2019; status: completed.
02
Drugs
oxytocin
03
Conditions
uterine atony
Beyond the preview
Go deeper on IRCT20120430009593N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120430009593N11.